Log In
Print
BCIQ
Print
Print this Print this
 

DPX-Survivac

  Manage Alerts
Collapse Summary General Information
Company Immunovaccine Inc.
DescriptionVaccine targeting survivin-expressing solid tumors using DepoVax delivery technology
Molecular Target Survivin (BIRC5)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today